Designation of Collaboration Targets. Exhibit 3.3(a) identifies the Collaboration Targets as of the Effective Date, including, as applicable, the Substitution Target and Monospecific Target (the “Initial Collaboration Targets”).
Appears in 2 contracts
Sources: Collaboration and License Agreement (Lyell Immunopharma, Inc.), Collaboration and License Agreement (Lyell Immunopharma, Inc.)